Information sent to healthcare professionals in July about the safety of medicines

Monthly lists of letters for healthcare professionals on the safety of medicines

3 August 2011

Letters sent to healthcare professionals in July 2011 to inform of new safety information and advice.

 Date issued  Product  Safety information
18 July 2011 Cardioxane (dexrazoxane)  Restricted usePDF file (opens in new window) (30Kb) 
28 July 2011  Thyrogen (thyrotropin alfa)  Update on supply and treatment recommendationsPDF file (opens in new window) (63Kb) 
29 July 2011  Actos, Competact (pioglitazone)  Small increased risk of bladder cancerPDF file (opens in new window) (77Kb) 
29 July 2011  Multaq (dronedarone)  Information following preliminary study results showing increased cardiovascular riskPDF file (opens in new window) (1057Kb) 

Page last modified: 03 August 2011